Combined with Ki67 is gradual up‐regulation with tumor progression,7 our results indicated that KRT17 and CRISP2 are possible biomarkers for different histological stages of cervical squamous cancer, this findings that may provide new targets for mechanistic studies and adjuvant diagnosis or therapy for cervical cancer. The gene discussed is CRISP2; the disease is cervical squamous cell carcinoma.